Новости

Russian superconductor corporation and TVEL agreed to collaborate in the realization of superconducting projects. Following the meeting the parties decided to unite efforts to establish an inductive energy storage (CEOP), magnetic resonance imaging (MRI), a compact superconducting cyclotron for medical purposes, as well as obtaining high-temperature superconducting materials.

TVEL will help Russian superconductor regarding research, consultancy and technological support to develop these products.

Also in the final protocol, signed by the parties identified the possibility of involving other stakeholders to implement these projects, including the corporation Rusnano. In the case of commercially attractive results as priority sites for industry parties have decided to use the capabilities of organizations involved in TVEL.
In addition to these aspects of cooperation in joint projects will provide for established TVEL (at JSC CMW, Glazov) production of low-temperature superconductor (LTS) in-Russian market for its implementation. LTS is a key element in creating spin, MRI and superconducting cyclotron. Until 2014, virtually all produced by JSC "CMP" low-temperature superconductor shipped abroad in the framework of the obligations of the Russian Federation in the international research project to build a nuclear fusion reactor ITER (based in France).
As previously reported, Russian superconductor started in 2008 to develop products based on the use of low-temperature superconductors - MRI, the spin, cyclotron. To date, some of them completed the research and the transition to development work. To perform an extensive co-operation projects, which included leading research organizations and groups of Rosatom, the Russian Academy of Sciences, universities, private companies. Creating a full-scale experimental designs LTS-equipment is planned in 2012-2014.
According to the CEO of Russian superconductor Alexander Katsay, interaction with a world leader in the design and manufacture of low-temperature superconductor could lift the pace of R&D reaching a qualitatively new level, as well as attract additional investor interest in the promising innovations, which are designed to mass use in energy and medical diagnostics. "The effect of this interaction will be the system, the results of its positive impact on the operation of research organizations involved in the project, the producer of low-temperature superconductor and its products, as well as what is most important for consumers of power engineering and medical services", - said Alexander Katsay.